Infographics - Diphtheria Vaccine Market

Diphtheria is a serious infection caused by strains of bacteria called Corynebacterium diphtheriae that make a toxin. It is the toxin that can cause people to get sick. Diphtheria bacteria spread from person to person, usually through respiratory droplets, like from coughing or sneezing. The bacteria make a toxin that kills healthy tissues in the respiratory system. Within two to three days, the dead tissue forms a thick, gray coating that can build up in the throat or nose. Vaccines are available that help prevent diphtheria, an infection caused by Corynebacterium diphtheriae bacteria. There are four kinds of Vaccines used in the U.S. to protect against diphtheria, all of which also provide protection against other diseases such as tetanus, and pertussis. The Vaccines are as follow: Diphtheria and tetanus (DT) Vaccines, Diphtheria, tetanus, and pertussis (DTaP) Vaccines, Tetanus and diphtheria (Td) Vaccines, and Tetanus, diphtheria, and pertussis (Tdap) Vaccines.

Market Dynamics

Increase in the government and non-government organizations initiatives to develop diphtheria Vaccines and increase in the awareness among people regarding importance of diphtheria Vaccine is expected to drive the market growth. Moreover, increase in the prevalence of bacterial infection such as diphtheria and tetanus is expected to drive the market growth for the forecast period. For instance, according to an article published in national library of medicine in June 2021, there were around 2,243 cases of diphtheria in Middle East during the period between 2019 to 2020. Out of which, about 44% (978/2243, 43.6%) of the cases involved children aged 5 to 15 years. Respiratory tract infection was the predominant symptom (2044/2243, 91.1%), followed by pseudomembrane (1822/2243, 81.2%).

Key features of the study:

This report provides in-depth analysis of the global diphtheria vaccine market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global diphtheria vaccine market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include AJ Vaccines A/S., BIONET-ASIA, GlaxoSmithKline plc., MassBiologics, Meiji Holdings Co., Ltd., Merck & Co., Inc, Panacea Biotec, Sanofi, Serum Institute of India Pvt. Ltd., Bharat Biotech, and BB – NCIPD Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global diphtheria vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global diphtheria vaccine market

Detailed Segmentation:

Global Diphtheria Vaccine Market, By Vaccine Type:
- DTaP Vaccine
- DT Vaccine
- Tdap Vaccine
- Td Vaccine
Global Diphtheria Vaccine Market, By Age Group:
- Pediatrics
- Adults
Global Diphtheria Vaccine Market By End User:
- Hospitals
- Clinics
- Vaccination Centers
Global Diphtheria Vaccine Market, By Region:
- North America
  - By Country:
    - U.S.
    - Canada
- Latin America
  - By Country:
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - By Country:
    - Germany
    - U.K.
    - France
    - Italy
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - By Country
    - China
    - India
    - Japan
    - Australia
    - South Korea
    - ASEAN
    - Rest of Asia Pacific
- Middle East
  - By Country:
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - By Country/Region:
    - South Africa
    - Central Africa
    - North Africa
Company Profiles
- AJ Vaccines A/S.*
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- BIONET-ASIA
- GlaxoSmithKline plc.
- MassBiologics
- Meiji Holdings Co., Ltd.
- Merck & Co., Inc
- Panacea Biotec
- Sanofi
- Serum Institute of India Pvt. Ltd.
- Bharat Biotech
- BB – NCIPD Ltd.

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot, By Vaccine Type
  - Market Snapshot, By Age Group
  - Market Snapshot, By End User
  - Market Snapshot, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Market Opportunities
- Impact Analysis
- Recent Product Launches
- Merger, Acquisition, Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
- Pipeline Analysis
- Technological Advancement
Global Diphtheria Vaccine Market - Impact of Coronavirus (Covid-19) Pandemic
- Economic Impact
- COVID-19 Epidemiology
- Impact on Supply and Demand
Global Diphtheria Vaccine Market, By Vaccine Type, 2017 – 2030, (US$ Million)
- Introduction
  - Market Share Analysis, 2022 and 2030 (%)
  - Y-o-Y Growth Analysis, 2017 – 2030
  - Segment Trends
- DTaP Vaccine
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- DT Vaccine
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Tdap Vaccine
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Td Vaccine
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
Global Diphtheria Vaccine Market, By Age Group, 2017 – 2030, (US$ Million)
- Introduction
  - Market Share Analysis, 2022 and 2030 (%)
  - Y-o-Y Growth Analysis, 2017 – 2030
  - Segment Trends
- Paediatrics
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Adults
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
Global Diphtheria Vaccine Market, By End User, 2017 – 2030, (US$ Million
- Introduction
  - Market Share Analysis, 2022 and 2030 (%)
  - Y-o-Y Growth Analysis, 2017 – 2030
  - Segments Trends
- Hospitals
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Clinics
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Vaccination Centers
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
Global Diphtheria Vaccine Market, By Region, 2017 – 2030, (US$ Million)
- Introduction
  - Market Share Analysis, By Region, 2022 and 2030 (%)
  - Y-o-Y Growth Analysis, For Regions, 2017–2030
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type , 2017 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type , 2017 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type , 2017 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type , 2017 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
    - China
    - India
    - Japan
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type , 2017 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type , 2017 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
    - North Africa
    - Central Africa
    - South Africa
Competitive Landscape
- AJ Vaccines A/S.*
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- BIONET-ASIA
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- GlaxoSmithKline plc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- MassBiologics
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Meiji Holdings Co., Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Merck & Co., Inc
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Panacea Biotec
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Sanofi
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Serum Institute of India Pvt. Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Bharat Biotech
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- BB – NCIPD Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
Section
- Research Methodology
- About Us

*Browse 34 market data tables and 30 figures on “Global Diphtheria Vaccine Market” - Global forecast to 2030

View Our Licence Options

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now

Credibility and Certifications

860519526

9001:2015

27001:2022

DIPHTHERIA VACCINE MARKET ANALYSIS

Diphtheria Vaccine Market

Need a Custom Report?

EXISTING CLIENTELE